Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells

Nucleic Acids Research

Volumn 36, Issue 1, 2008, Pages 76-93

  Bourdeau, Véronique ^a   Deschênes, Julie ^a   Laperrière, David ^a   Aid, Malika ^a   White, John H ^b   Mader, Sylvie ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLOHEXIMIDE; DNA; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; MINICHROMOSOME MAINTENANCE PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F;

ARTICLE; BINDING SITE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; ESTROGEN RESPONSIVE ELEMENT; GENE CONTROL; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MODULATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; E2F TRANSCRIPTION FACTORS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS;

EID: 38349095526     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm945     Document Type: Article

References (96)

1. Couse,J.F. and Korach,K.S. (1999) Estrogen receptor null mice: What have we learned and where will they lead us? Endocrine Rev., 20, 358-417.
2. McEwen,B.S. and Alves,S.E. (1999) Estrogen actions in the central nervous system. Endocrine Rev., 20, 279-307.
3. Jordan,V.C. (2001) Estrogen, selective estrogen receptor modulation, and coronary heart disease: Something or nothing. J. Natl Canc. Inst., 93, 2-4.
4. Ali,S. and Coombes,R.C. (2002) Endocrine-responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer, 2, 101-112.
5. Simpson,E.R. (2003) Sources of estrogen and their importance. J. Steroid Biochem. Mol. Biol., 86, 225-230.
6. Nilsson,S., Makela,S., Treuter,E., Tujague,M., Thomsen,J., Andersson,G., Enmark,E., Pettersson,K., Warner,M. et al. (2001) Mechanisms of estrogen action. Physiol. Rev., 81, 1535-1565.
7. Robinson-Rechavi,M., Escriva Garcia,H. and Laudet,V. (2003) The nuclear receptor superfamily. J. Cell Sci., 116, 585-586.
8. Kishimoto,M., Fujiki,R., Takezawa,S., Sasaki,Y., Nakamura,T., Yamaoka,K., Kitagawa,H. and Kato,S. (2006) Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications. Endocr. J., 53, 157-172.
9. Metivier,R., Reid,G. and Gannon,F. (2006) Transcription in four dimensions: Nuclear receptor-directed initiation of gene expression. EMBO Rep., 7, 161-167.
10. Mader,S., Chambon,P. and White,J.H. (1993) Defining a minimal estrogen receptor DNA binding domain. Nucleic Acids Res., 21, 1125-1132.
11. Schwabe,J.W., Chapman,L., Finch,J.T. and Rhodes,D. (1993) The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements. Cell, 75, 567-578.
12. Walker,P., Germond,J.-E., Brown-Luedi,M., Givel,F. and Wahli,W. (1984) Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII gene. Nucleic Acids Res., 12, 8611-8626.
13. Klein-Hitpass,L., Ryffel,G.U., Heitlinger,E. and Cato,A.C. (1988) A 13bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucleic Acids Res., 16, 647-663.
14. Klinge,C.M. (2001) Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res., 29, 2905-2919.
15. Sanchez,R., Nguyen,D., Rocha,W., White,J.H. and Mader,S. (2002) Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays, 24, 244-254.
16. Driscoll,M.D., Sathya,G., Muyan,M., Klinge,C.M., Hilf,R. and Bambara,R.A. (1998) Sequence requirements for estrogen receptor binding to estrogen response elements. J. Biol. Chem., 273, 29321-29330.
17. Kulakosky,P.C., McCarty,M.A., Jernigan,S.C., Risinger,K.E. and Klinge,C.M. (2002) Response element sequence modulates estrogen receptor alpha and beta affinity and activity. J. Mol. Endocrinol., 29 137-152.
18. Nguyen,D., Bail,M., Pesant,G., Dupont,V.N., Rouault,E., Deschenes.J., Rocha,W., Melancon,G., Steinberg,S.V. et al. (2007) Rational design of an estrogen receptor mutant with altered DNA-binding specificity. Nucleic Acids Res., 35, 3465-3477.
19. Bai,Y. and Giguere,V. (2003) Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells. Mol. Endocrinol., 17, 589-599.
20. Gustafsson,J.A. (2006) ERbeta scientific visions translate to clinical uses. Climacteric, 9, 156-160.
21. Leo,C. and Chen,J.D. (2000) The SRC family of nuclear receptor coactivators. Gene, 245, 1-11.
22. Rosenfeld,M.G. and Glass,C.K. (2001) Coregulator codes of transcriptional regulation by nuclear receptors. J. Biol. Chem., 276, 36865-36868.
23. Rachez,C. and Freedman,L.P. (2001) Mediator complexes and transcription. Curr. Opin. Cell Biol., 13, 274-280.
24. Dilworth,F.J. and Chambon,P. (2001) Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene, 20, 3047-3054.
25. McDonnell,D.P. and Norris,J.D. (2002) Connections and regulation of the human estrogen receptor. Science, 296, 1642-1644.
26. McKenna,N.J. and O'Malley,B.W. (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell, 108, 465-474.
27. Belandia,B. and Parker,M.G. (2003) Nuclear receptors: A rendezvous for chromatin remodeling factors. Cell, 114, 277-280.
28. Forster,C., Makela,S., Warri,A., Kietz,S., Becker,D., Hultenby,K., Warner,M. and Gustafsson,J.A. (2002) Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc. Natl Acad Sci. USA, 99, 15578-15583.
29. Leygue,E., Dotzlaw,H., Watson,P.H. and Murphy,L.C. (1998) Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res., 58, 3197-3201.
30. Roger,P., Sahla,M.E., Makela,S., Gustallssonj.A., Baldet,P. and Rochefort,H. (2001) Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res., 61, 2537-2541.
31. Kushner,P.J., Agard,D.A., Greene,G.L., Scanlan,T.S., Shiau,A.K., Uht,R.M. and Webb,P. (2000) Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol., 74, 311-317.
32. Safe,S. (2001) Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam. Horm., 62 231-252.
33. Kalaitzidis,D. and Gihnore,T.D. (2005) Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol. Metab., 16, 46-52.
34. Migliaccio,A., Di Domenico,M., Castoria,G., de Falco,A., Bontempo,P., Nola,E. and Auricchio,F. (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J., 15, 1292-1300.
35. Sun,M., Paciga,J.E., Feldman,R.I., Yuan,Z., Coppola,D., Lu,Y.Y., Shelley,S.A., Nicosia,S.V. and Cheng,J.Q. (2001) Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Cancer Res., 61, 5985-5991.
36. Pedram,A., Razandi,M., Aitkenhead,M., Hughes,C.C. and Levin,E.R. (2002) Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J. Biol. Chem., 277, 50768-50775.
37. Simoncini,T., Fornari,L., Mannella,P., Varone G., Caruso,A., Liao,J.K. and Genazzani,A.R. (2002) Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase. Steroids, 67, 935-939.
38. Pedram,A., Razandi,M. and Levin,E.R. (2006) Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol., 20 1996-2009.
39. Filardo,E.J., Quinn,J.A., Bland,K.I. and Frackelton,A.R.,Jr. (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol., 14, 1649-1660.
40. Maggiolini,M., Vivacqua,A., Fasanella,G., Recchia,A.G., Sisci,D., Pezzi,V., Montanaro,D., Musti,A.M., Picard,D. et al. (2004) The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J. Biol. Chem., 279, 27008-27016.
41. Revankar,C.M., Cimino,D.F., Sklar,L.A., Arterburn,J.B. and Prossnitz,E.R. (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science, 307, 1625-1630.
42. Thomas,P., Pang,Y., Filardo,E.J. and Dongj. (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology, 146, 624-632.
43. Funakoshi,T., Yanai,A., Shinoda,K., Kawano,M.M. and Mizukami,Y. (2006) G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem. Biophys. Res. Commun., 346, 904-910.
44. Soulez,M. and Parker,M.G. (2001) Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J. Mol. Endocrinol., 27, 259-274.
45. Frasor,J., Danes,J.M., Komm,B., Chang,K.C., Lyttle,C.R. and Katzenellenbogen,B.S. (2003) Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology, 144, 4562-4574.
46. Lin,C.Y., Strom,A., Vega,V.B., Kong,S.L., Yeo,A.L., Thomsen,J.S., Chan,W.C., Doray,B., Bangarusamy,D.K. et al. (2004) Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol., 5, R66.
47. Cicatiello,L., Scafoglio,C., Altucci,L., Cancemi,M., Natoli,G., Facchiano,A., Iazzetti,G., Calogero,R., Biglia,N. et al. (2004) A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome. J. Mol. Endocrinol., 32, 719-775.
48. Carroll,J.S., Liu,X.S., Brodsky,A.S., Li,W., Meyer,C.A., Szary,A.J., Eeckhoute,J., Shao,W., Hestermann,E.V et al. (2005) Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell, 122, 33-43.
49. Vega,V.B., Lin,C.Y., Lai,K.S., Kong,S.L., Xie,M., Su,X., Teh,H.F., Thomsen,J.S., Yeo,A.L. et al. (2006) Multiplatform genome-wide identification and modeling of functional human estrogen receptor binding sites. Genome Biol., 7, R82.
50. Carroll,J.S., Meyer,C.A., Song,J., Li,W., Geistlinger,T.R., Eeckhoute,J., Brodsky,A.S., Kenton,E.K., Fertuck,K.C. et al. (2006) Genorne-wide analysis of estrogen receptor binding sites. Nat. Genet., 38 1289-1297.
51. Bourdeau,V., Deschenes,J., Metivier,R., Nagai,Y., Nguyen,D., Bretschneider,N., Gannon,F., White,J.H. and Mader,S. (2004) Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol. Endocrinol., 18, 1411-1427.
52. Deschenes,J., Bourdeau,V., White,J.H. and Mader,S. (2007) Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 KB of upstream flanking sequences. J. Biol. Chem., 282, 17335-17339.
53. Rocha,W., Sanchez,R., Deschenes,J., Auger,A., Hebert,E., White,J.H. and Mader,S. (2005) Opposite effects of histone deacetylase inhibitors on glucocorticoid and estrogen signaling in human endometrial Ishikawa cells. Mol. Pharmacol., 68, 1852-1862.
54. Dayan,G., Lupien,M., Auger,A., Anghel,S.I., Rocha,W., Croisetiere,S., Katzenellenbogen,J.A. and Mader,S. (2006) Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha. Mol. Pharmacol., 70, 579-588.
55. Wettenhall,J.M., Simpson,K.M., Satterlcy,K. and Smyth,G.K. (2006) affylmGUI: A graphical user interface for linear modeling of single channel microarray data. Bioinformatics, 22, 897-899.
56. Irizarry,R.A., Bolstad,B.M., Collin,F., Cope,L.M., Hobbs,B. and Speed,T.P. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res., 31, e15.
57. Smyth,G.K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol., 3, Article3.
58. Karolchik,D., Baertsch, Diekhans,M., Furey,T.S., Hinrichs,A., Lu,Y.T., Roskin,K.M., Schwartz,M., Sugnet,C.W. et al. (2003) The UCSC Genome Browser Database. Nucleic Acids Res., 31, 51-54.
59. Pruitt,K.D., Tatusova,T. and Maglott,D.R. (2005) NCBI Reference Sequence (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res., 33, D501-D504.
60. Wasserman,W.W. and Sandelin,A. (2004) Applied bioinformatics for the identification of regulatory elements. Nat. Rev. Genet., 5, 276-287.
61. Wang,T.T., Tavera-Mendoza,L.E., Laperriere,D., Libby,E., MacLeod,N.B., Nagai,Y., Bourdeau,V., Konstorum,A., Lallemant,B. et al. (2005) Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target- genes. Mol. Endocrinol., 19 2685-2695.
62. Laperriere,D., Wang,T.T., White J.H., and Mader,S. (2007), Widespread Alu repeat-driven expansion of consensus DR2 retinoic acid response elements during primate evolution. BMC Genomics, 8, 23.
63. Matys,V., Kel-Margoulis,O.V., Fricke,E., Liebich,I., Land,S., Barre-Dirrie,A., Reuter,I., Chekmenev,D., Krull,M. et al. (2006) TRANSFAC andits module TRANSCompel: Transcriptional gene regulation in eukaryotes. Nucleic Acids Res., 34, D108-D110.
64. Jin,V.X., Sun,H., Pohar,T.T., Liyanarachchi,S., Palaniswamy,S.K., Huang,T.H. and Davuluri,R.V. (2005) ERTargetDB: An integral information resource of transcription regulation of estrogen receptor target genes. J. Mol. Endocrinol., 35, 225-230.
65. O'Lone,R., Frith,M.C., Karlsson,E.K. and Hansen,U. (2004) Genomic targets of nuclear estrogen receptors. Mol. Endocrinol., 18, 1859-1875.
66. Balmer,J.E. and Blomhoff,R. (2005) A robust characterization of retinoic acid response elements based on a comparison of sites in three species. J. Steroid Biochem. Mol. Biol., 96, 347-354.
67. Siepel,A., Bejerano,G., Pedersen,J.S., Hinrichs,A.S., Hou,M., Rosenbloom,K., Clawson,H., Spieth,J., Hillier,L.W. et al. (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res., 15, 1034-1050.
68. Ho Sui,S.J., Mortimer,J.R., Arenillas,D.J., Brumm,J., Walsh,C.J., Kennedy,B.P. and Wasserman,W.W. (2005) oPOSSUM: Identification of over-represented transcription factor binding sites in co-expressed genes. Nucleic Acids Res., 33, 3154-3164.
69. Jin,V.X., Rabinovich,A., Squazzo,S.L., Green,R. and Farnham,P.J. (2006) A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation micro-array data - a case study using E2F1. Genome Res., 16, 1585-1595.
70. Creighton,C.J., Cordero,K.E., Larios,J.M., Miller,R.S., Johnson,M.D., Chinnaiyan,A.M., Lippman,M.E. and Rae,J.M. (2006) Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors. Genome Biol., 7 R28.
71. Rac,J.M., Johnson,M.D., Scheys,J.O., Cordero,K.E., Larios,J.M. and Lippman,M.E. (2005) GREB 1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res. Treat., 92, 141-149.
72. van der Burg,B., van Selm-Miltenburg,A.J., de Laat,S.W. and van Zoelen,E.J. (1989) Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol. Cell. Endocrinol., 64, 223-228.
73. Gutierrez,G.J. and Ronai,Z. (2006) Ubiquitin and SUMO systems in the regulation of mitotic checkpoints. Trends Biochem. Sci., 31, 324-332.
74. Scholtens,D., Miron,A., Merchant,F.M., Miller,A., Miron,P.L., Iglehart,J.D. and Gentleman,R. (2004) Analyzing factorial designed microarray experiments. J. Multivariate Anal., 90, 19-43.
75. Blobel,G.A., Sieff,C.A. and Orkin,S.H. (1995) Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor. Mol. Cell. Biol., 15, 3147-3153.
76. Holth,L.T., Sun,J.M., Coutts,A.S., Murphy,L.C. and Davie,J.R. (1997) Estrogen receptor diminishes DNA-binding activities of chicken GATA-1 and CACCC-binding proteins. DNA Cell Biol., 16, 1477-1482.
77. Prall,O.W., Rogan,E.M., Musgrove,E.A., Watts,C.K. and Sutherland,R.L. (1998) c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol. Cell. Biol., 18, 4499-4508.
78. Doisneau-Sixou,S.F., Sergio,C.M., Carroll,J.S., Hui,R., Musgrove,E.A. and Sutherland,R.L. (2003) Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr. Relat. Cancer, 10, 179-186.
79. Zhao,F., Xuan,Z., Liu,L. and Zhang,M.Q. (2005) TRED: A Transcriptional Regulatory Element Database and a platform for in silico gene regulation studies. Nucleic Acids Res., 33, D103-D107.
80. Cappellen,D., Schlange,T., Bauer,M., Maurer,F. and Hynes,N.E. (2007) Novel c-MYC target genes mediate differential effects on cell proliferation and migration. EMBO Rep., 8, 70-76.
81. Rodrik,V., Gomes,E., Hui,L., Rockwell,P. and Foster,D.A. (2006) Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells. FEBS Lett., 580, 5647-5652.
82. Foster,J.S., Henley,D.C., Ahamed,S, and Wimalasena,J. (2001) Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol. Metab. 12, 320-327.
83. Otsuki,Y., Tanaka,M., Kamo,T., Kitanaka,C., Kuchino,Y. and Sugimura,H. (2003) Guanine nucleotide exchange factor, Tiam1, directly binds to c-Myc and interferes vith c-Myc-mediated apoptosis in rat-1 fibroblasts. J. Biol. Chem., 278, 5132-5140.
84. Hirai,H., Izutsu,K., Kurokawa,M. and Mitani,K. (2001) Oncogenic mechanisms of Evi-1 protein. Cancer Chemother. Pharmacol., 48, (Suppl. 1), S35-S40.
85. Koipally,J., Renold,A., Kim,J. and Georgopoulos,K. (1999) Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J., 18, 3090-3100.
86. Brunnberg,S., Pettersson,K., Rydin,E., Matthews,J., Hanberg,A. and Pongratz,I. (2003) The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription. Proc. Natl Acad. Sci. USA, 100, 6517-6522.
87. Ohtake,F., Takeyama,K., Matsumoto,T. Kitagawa,H., Yamamoto,Y., Nohara,K., Tohyama,C., Krust,A., Mimura,J. et al. (2003) Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature, 423, 545-550.
88. Sukhatme,V.P. (1990) Early transcriptional events in cell growth: The Egr family. J. Am. Soc. Nephrol., 1, 859-866.
89. Khachigian,L.M. and Collins,T. (1998) Early growth response factor 1: A pleiotropic mediator of inducible gene expression. J. Mol. Med., 76, 613-616.
90. Chen,C.C., Lee,W.R. and Safe,S. (2004) Egr-1 is activated by 17beta-estradiol in MCF-7 cells by mitogen-activated protein kinase-dependent phosphorylation of ELK-1. J. Cell. Biochem., 93, 1063-1074.
91. Kato,K., Toki,T., Shimizu,M., Shiozawa,T., Fujii,S., Nikaido,T. and Konishi,I. (2003) Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: Correlation with expression of Ki-67 and estrogen and progesterone receptors. Int. J. Gynecol. Pathol., 22, 334-340.
92. Di Stefano,L., Jensen,M.R. and Helin,K. (2003) E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J., 22, 6289-6298.
93. Christensen,J., Cloos,P., Toftegaard,U., Klinkenberg,D., Bracken,A.P., Trinh,E., Heeran,M., Di Stefano,L. and Helin,K. (2005) Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription. Nucleic Acids Res., 33, 5458-5470.
94. Trimarchi,J.M., Fairchild,B., Verona,R., Moberg,K., Andon,N. and Lees,J.A. (1998) E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl Acad. Sci. USA, 95, 2850-2855.
95. Cartwright,P., Muller,H., Wagener,C., Holm,K. and Helin,K. (1998) E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene, 17, 611-623.
96. Ogawa,H., Ishiguro,K., Gaubatz,S., Livingston,D.M. and Nakatani,Y. (2002) A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science, 296, 1132-1136.